Yes, here is a link to the article titled below.....you made comments here about it at the time (congratulating Fortuno as he predicted that PR before announced, so your memory must have been influenced by the market reaction to these PRs, yawn and forget about it :

CytoDyn Files an IND and a Phase 2 Protocol with the FDA for the Treatment of NASH with Leronlimab

https://www.cytodyn.com/newsroom/press-releas...th-the-fda